Patents by Inventor Xingtao Tian

Xingtao Tian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220006292
    Abstract: A power system dispatching method considering voltage sensitive load reserve is provided, with which a power system dispatching model constituted by a ground state operating point model of the power system, an evaluation model of the voltage sensitive load regulation range and an optimization objective of power system dispatch is established, by solving the power system dispatching model, a power system dispatching solution considering voltage sensitive load reserve is obtained.
    Type: Application
    Filed: May 27, 2021
    Publication date: January 6, 2022
    Inventors: Bin WANG, Haoran YU, Hongbin SUN, Zijin LI, Qinglai GUO, Cunping WANG, Zhaoguang PAN, Yifan SONG, Xingtao TIAN
  • Patent number: 8933106
    Abstract: The invention relates to 2-(4-Substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof. Specifically, the invention relates to compounds of formula I or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the description. The compounds of formula I of the invention are a type of anti-HIV active compounds having new backbone structure.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: January 13, 2015
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Lan Xie, Xingtao Tian, Kuo-Hsiung Lee, Shibo Jiang, Hong Lu
  • Publication number: 20120053213
    Abstract: The invention relates to 2-(4-Substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof. Specifically, the invention relates to compounds of formula I or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the description. The compounds of formula I of the invention are a type of anti-HIV active compounds having new backbone structure.
    Type: Application
    Filed: September 28, 2009
    Publication date: March 1, 2012
    Applicant: INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA
    Inventors: Lan Xie, Xingtao Tian, Kuo-Hsiung Lee, Shibo Jiang, Hong Lu